This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Whether looking at biotech beauty and what “clean” really means, effectively dealing with obesity, or biohacking our biology, wellness-engaged health citizens are not interesting in the shiny new thing without data backing up claims. Being Missourian in spirit and intent: seeking the science and the evidence.
This global crisis has tested our ability as a civilization to respond to publichealth emergencies and mitigate the impact of geopolitical interference impeding our collective adherence to sensible policies geared towards disease prevention. Effective publichealth communication is the cornerstone of any pandemic response.
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. However, we are still missing the mark with patient involvement to make durable healthcare change towards a culture of patient centricity.
Increasingly, as patients bear more first-dollar costs through high-deductible health plans, co-payments and co-insurance sharing, the patient-as-payor has become more sensitive to these prices. Chan School of PublicHealth with POLITICO looked into Americans’ Health and Education Priorities for the New Congress in 2019.
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. 2 Digital health is a large (+$900bn by 2032) and growing (13.6%
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content